Iron chelation therapy in myelodysplastic syndromes: evidence-based rationale and comparison of guidelines | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.04.2010 | Short Review

Iron chelation therapy in myelodysplastic syndromes: evidence-based rationale and comparison of guidelines

verfasst von: Michael Pfeilstöcker

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Austrian consensus recommendations for the treatment of patients with multiple myeloma

Nächster Artikel Allogeneic stem cell transplantation (SCT) in Ph+ CML: still a therapeutic option?

Titel: Iron chelation therapy in myelodysplastic syndromes: evidence-based rationale and comparison of guidelines
verfasst von: Michael Pfeilstöcker
Publikationsdatum: 01.04.2010
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 1/2010
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-010-0179-6

Weitere Artikel der Ausgabe 1/2010

Biomarkers of angiogenesis and their role in clinical oncology

Short Review

Austrian consensus recommendations for the treatment of patients with multiple myeloma

Consensus Report

CECOG’s services at a glance

CECOG News

Swiss trials in thoracic oncology

Special Report

Haemolytic anaemia triggered by antitumoural “biological agents” and immunotherapies with monoclonal antibodies: short review of the literature

Special Report

Qualitative and quantitative assessment of endpoints in clinical trials

Short Review